Company / Debt per Share
Twist Bioscience Corp Debt per Share History
FY2018-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$0.04
FY2020
5-year range
-
FY2018-FY2020
Trend
-77.7%
vs FY2019
Sector context
#82 of 85
Health Care
What the data says
Among 85 Health Care companies, Twist Bioscience Corp is in the top 4% for debt per share. Improved from $2584.32 to $0.04 over the past 2 years.
Based on SEC 10-K filings.
0.04 in FY2020.
Improved from $2584.32 to $0.04 over the past 2 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 4% in Health CareTop 4% of 85This company $0.04 Sector average $122.37
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2020, debt per share decreased 77.7% year-over-year.
- Ranks #82 out of 85 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | $0.04 | -77.7% |
| FY2019 | $0.16 | -100.0% |
| FY2018 | $2584.32 | - |
| FY2017 | - | - |
As of FY2020 · SEC 10-K · Updated Feb 28, 2026